IT1248726B - Processo per indurre l'espressione funzionale di recettori dopaminergici in cellule tumorali - Google Patents

Processo per indurre l'espressione funzionale di recettori dopaminergici in cellule tumorali

Info

Publication number
IT1248726B
IT1248726B IT02061790A IT2061790A IT1248726B IT 1248726 B IT1248726 B IT 1248726B IT 02061790 A IT02061790 A IT 02061790A IT 2061790 A IT2061790 A IT 2061790A IT 1248726 B IT1248726 B IT 1248726B
Authority
IT
Italy
Prior art keywords
inducing
dopaminergic receptors
tumour cells
functional expression
growth factor
Prior art date
Application number
IT02061790A
Other languages
English (en)
Italian (it)
Other versions
IT9020617A0 (enExample
IT9020617A1 (it
Inventor
Pierfranco Spano
Cristina Missale
Original Assignee
Uni Degli Studi Brescia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Brescia filed Critical Uni Degli Studi Brescia
Priority to IT02061790A priority Critical patent/IT1248726B/it
Publication of IT9020617A0 publication Critical patent/IT9020617A0/it
Publication of IT9020617A1 publication Critical patent/IT9020617A1/it
Application granted granted Critical
Publication of IT1248726B publication Critical patent/IT1248726B/it

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT02061790A 1990-06-12 1990-06-12 Processo per indurre l'espressione funzionale di recettori dopaminergici in cellule tumorali IT1248726B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT02061790A IT1248726B (it) 1990-06-12 1990-06-12 Processo per indurre l'espressione funzionale di recettori dopaminergici in cellule tumorali

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02061790A IT1248726B (it) 1990-06-12 1990-06-12 Processo per indurre l'espressione funzionale di recettori dopaminergici in cellule tumorali

Publications (3)

Publication Number Publication Date
IT9020617A0 IT9020617A0 (enExample) 1990-06-12
IT9020617A1 IT9020617A1 (it) 1991-12-12
IT1248726B true IT1248726B (it) 1995-01-26

Family

ID=11169623

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02061790A IT1248726B (it) 1990-06-12 1990-06-12 Processo per indurre l'espressione funzionale di recettori dopaminergici in cellule tumorali

Country Status (1)

Country Link
IT (1) IT1248726B (enExample)

Also Published As

Publication number Publication date
IT9020617A0 (enExample) 1990-06-12
IT9020617A1 (it) 1991-12-12

Similar Documents

Publication Publication Date Title
IL83012A0 (en) Immunoconjugates for use in tumor therapy and their production
NZ226005A (en) Covalent conjugates of a human cytokine and a human immunoglobulin, processes for their manufacture and pharmaceutical compositions thereof
GR3033630T3 (en) Gene expression elements and the production of chimeric mouse-human antibodies.
HUT37957A (en) Process for production of dna, coding neurotic factor of human tumour and its application in production of medical preparatives containing polipeptid and as reagent one polipeptid in accordance with this factor
EP0463152A4 (en) Method of inhibiting angiogenesis of tumors
ZA861403B (en) Neovascularization inhibitors and methods for their production and use
ATE140483T1 (de) Natürlicher killerzellen-stimulationsfaktor
CA2026783A1 (en) Use of il-7 in providing medications for stimulation of platelet production
DE69635924D1 (de) Isolierung und züchtung von schwannzellen
ITRM920891A0 (it) Perfezionamento nei pacemaker per permetterne la sostituzione rapida esicura senza interruzione della stimolazione elettrica del cuore.
GR3006073T3 (enExample)
GB2217330B (en) Lipolytic material associated with cachexia inducing tumours, preparations,production and uses thereof.
NZ281482A (en) The stimulation of erythropoiesis using thrombopoietin and erythropoietin
GR3025134T3 (en) Process for preparing a concentrate of blood coagulation factor XI with high specific activity, appropriate for therapeutic use
DK522186A (da) Melatoninmaterialer og deres anvendelser
ATE267599T1 (de) Verwendung von chelerythrin und strahlung in der tumortherapie
ATE109765T1 (de) N-alkoxyalkylamide von hydroxysauren und sie enthaltende hautbehandlungszubereitungen.
SG52537A1 (en) Methods and compositions for the treatment of cell proliferation disorders
ES2055163T3 (es) Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion.
IT1248726B (it) Processo per indurre l'espressione funzionale di recettori dopaminergici in cellule tumorali
DE3684953D1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
AU623241B2 (en) An implantable medical instrument for stimulating a physiological function of a living thing with adjustable intensity of stimulation, and process of adjusting the intensity of stimulation
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
DE3872871D1 (de) Verwendung von metalloporphyrin zur umkehr des toxischen effekts der tumortherapie.
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970626